Multidrug resistance has increasingly become a problem and is causing more and more deaths every year, in particular among at risk categories such as the elderly, immunocompromised patients, ICU patients, etc. Since only a correct use of antimicrobial drugs can minimize spread of resistant bacteria, Professor Andrea Novelli (Florence, Italy) stresses the importance of evaluating pharmacokinetic and pharmacodynamic of the antimicrobial drugs.